loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X

List of All Manufacturers & Suppliers for 50450 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 MITOMYCIN (2)

filter

01 BRISTOL (2)

filter

01 INJECTABLE;INJECTION (2)

filter

01 20MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
INJECTABLE;INJECTION
20MG/VIAL **Federal Re...
MUTAMYCIN
USA
50450
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
INJECTABLE;INJECTION
5MG/VIAL **Federal Reg...
MUTAMYCIN
USA
50450
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 50450

Looking for CTD TGA MCC DOSSIER APPLICATION 50450 2

19

Bristol Laboratories Ltd, based in United Kingdom, is a pharmaceutical company.

One of their notable products is MITOMYCIN, with a corresponding application number 50450 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

Bristol Laboratories Ltd's MUTAMYCIN INJECTABLE;INJECTION, medication with 20MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of MITOMYCIN.

18

Bristol Laboratories Ltd, based in United Kingdom, is a pharmaceutical company.

One of their notable products is MITOMYCIN, with a corresponding application number 50450 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

Bristol Laboratories Ltd's MUTAMYCIN INJECTABLE;INJECTION, medication with 5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of MITOMYCIN.

Post Enquiry
POST ENQUIRY